Logo
x

Search

Subscribe Now

All Posts by Date

Genmab Signs an Agreement with Tempus to Develop Novel Targets and Biomarkers for Cancer Indications

Genmab Signs an Agreement with Tempus to Develop Novel Targets and Biomarkers for Cancer Indications

  • September 10, 2019
Alexion Enters into an Exclusive License Agreement with Eidos to Develop and Commercialize AG10 in Japan

Alexion Enters into an Exclusive License Agreement with Eidos to Develop and Commercialize AG10 in Japan

  • September 10, 2019
Medtronic's MiniMed 670G Insulin Pump System Receives Reimbursement for Patients with T1D in Germany

Medtronic's MiniMed 670G Insulin Pump System Receives Reimbursement for Patients with T1D in Germany

  • September 10, 2019
BMS Reports Pooled Five Year Results of Opdivo (nivolumab) in Two P-III Studies for Advanced Non-Small Cell Lung Cancer

BMS Reports Pooled Five Year Results of Opdivo (nivolumab) in Two P-III Studies for Advanced Non-Small Cell Lung Cancer

  • September 10, 2019
Mallinckrodt to Divest its Subsidiary BioVectra for $250M

Mallinckrodt to Divest its Subsidiary BioVectra for $250M

  • September 10, 2019
Baxter to Acquire Cheetah Medical for ~$230M

Baxter to Acquire Cheetah Medical for ~$230M

  • September 10, 2019
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.